BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 26316167)

  • 1. Inhibition of CD147 expression by RNA interference reduces proliferation, invasion and increases chemosensitivity in cancer stem cell-like HT-29 cells.
    Chen J; Pan Y; He B; Ying H; Wang F; Sun H; Deng Q; Liu X; Lin K; Peng H; Cho WC; Wang S
    Int J Oncol; 2015 Oct; 47(4):1476-84. PubMed ID: 26316167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of CD147 expression by RNA interference inhibits HT29 cell proliferation, invasion and tumorigenicity in vitro and in vivo.
    Li R; Pan Y; He B; Xu Y; Gao T; Song G; Sun H; Deng Q; Wang S
    Int J Oncol; 2013 Dec; 43(6):1885-94. PubMed ID: 24064772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of CD147 gene expression via RNA interference reduces tumor cell invasion, tumorigenicity and increases chemosensitivity to paclitaxel in HO-8910pm cells.
    Zou W; Yang H; Hou X; Zhang W; Chen B; Xin X
    Cancer Lett; 2007 Apr; 248(2):211-8. PubMed ID: 16930823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis reveals that CD147/EMMPRIN confers chemoresistance in cancer stem cell-like cells.
    Kang MJ; Kim HP; Lee KS; Yoo YD; Kwon YT; Kim KM; Kim TY; Yi EC
    Proteomics; 2013 May; 13(10-11):1714-25. PubMed ID: 23554123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of CD147 gene expression via RNA interference reduces tumor cell invasion, tumorigenicity and increases chemosensitivity to cisplatin in laryngeal carcinoma Hep2 cells.
    Zhu C; Pan Y; He B; Wang B; Xu Y; Qu L; Bao Q; Tian F; Wang S
    Oncol Rep; 2011 Feb; 25(2):425-32. PubMed ID: 21165561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERK1/2 signalling pathway is involved in CD147-mediated gastric cancer cell line SGC7901 proliferation and invasion.
    Chen L; Pan Y; Gu L; Nie Z; He B; Song G; Li R; Xu Y; Gao T; Wang S
    Exp Biol Med (Maywood); 2013 Aug; 238(8):903-12. PubMed ID: 23828593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A small interfering CD147-targeting RNA inhibited the proliferation, invasiveness, and metastatic activity of malignant melanoma.
    Chen X; Lin J; Kanekura T; Su J; Lin W; Xie H; Wu Y; Li J; Chen M; Chang J
    Cancer Res; 2006 Dec; 66(23):11323-30. PubMed ID: 17145878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [RNAi-mediated silencing of CD147 inhibits the proliferation and infiltrations of leukemic cells SHI-1].
    Tu Y; Li Z; Tang A; Fei Y; Li H; Wu Q; He W
    Zhonghua Xue Ye Xue Za Zhi; 2014 Aug; 35(8):737-42. PubMed ID: 25152124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA interference targeting CD147 inhibits the proliferation, invasiveness, and metastatic activity of thyroid carcinoma cells by down-regulating glycolysis.
    Huang P; Chang S; Jiang X; Su J; Dong C; Liu X; Yuan Z; Zhang Z; Liao H
    Int J Clin Exp Pathol; 2015; 8(1):309-18. PubMed ID: 25755717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models.
    Schneiderhan W; Scheler M; Holzmann KH; Marx M; Gschwend JE; Bucholz M; Gress TM; Seufferlein T; Adler G; Oswald F
    Gut; 2009 Oct; 58(10):1391-8. PubMed ID: 19505879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNAi-mediated silencing of CD147 inhibits tumor cell proliferation, invasion and increases chemosensitivity to cisplatin in SGC7901 cells in vitro.
    Wang B; Xu YF; He BS; Pan YQ; Zhang LR; Zhu C; Qu LL; Wang SK
    J Exp Clin Cancer Res; 2010 Jun; 29(1):61. PubMed ID: 20525232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteome analysis of multidrug resistance of human oral squamous carcinoma cells using CD147 silencing.
    Kuang YH; Chen X; Su J; Wu LS; Li J; Chang J; Qiu Y; Chen ZS; Kanekura T
    J Proteome Res; 2008 Nov; 7(11):4784-91. PubMed ID: 18816083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpressions of RACK1 and CD147 associated with poor prognosis in stage T1 pulmonary adenocarcinoma.
    Zhong X; Li M; Nie B; Wu F; Zhang L; Wang E; Han Y
    Ann Surg Oncol; 2013 Mar; 20(3):1044-52. PubMed ID: 22592183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of CD147 gene expression via RNA interference reduces tumor cell proliferation, activation, adhesion, and migration activity in the human Jurkat T-lymphoma cell line.
    Chen X; Su J; Chang J; Kanekura T; Li J; Kuang YH; Peng S; Yang F; Lu H; Zhang JL
    Cancer Invest; 2008 Aug; 26(7):689-97. PubMed ID: 18608214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. F-Box Protein FBXO22 Mediates Polyubiquitination and Degradation of CD147 to Reverse Cisplatin Resistance of Tumor Cells.
    Wu B; Liu ZY; Cui J; Yang XM; Jing L; Zhou Y; Chen ZN; Jiang JL
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD147 mediates tumor cells invasion and multidrug resistance in hepatocellular carcinoma.
    Jia L; Xu H; Zhao Y; Jiang L; Yu J; Zhang J
    Cancer Invest; 2008 Dec; 26(10):977-83. PubMed ID: 19093255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A CD147-targeting siRNA inhibits the proliferation, invasiveness, and VEGF production of human malignant melanoma cells by down-regulating glycolysis.
    Su J; Chen X; Kanekura T
    Cancer Lett; 2009 Jan; 273(1):140-7. PubMed ID: 18778892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cleaved CD147 shed from the surface of malignant melanoma cells activates MMP2 produced by fibroblasts.
    Hatanaka M; Higashi Y; Fukushige T; Baba N; Kawai K; Hashiguchi T; Su J; Zeng W; Chen X; Kanekura T
    Anticancer Res; 2014 Dec; 34(12):7091-6. PubMed ID: 25503136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and functional analysis of variants of a cancer/testis antigen LEMD1 in colorectal cancer stem-like cells.
    Takeda R; Hirohashi Y; Shen M; Wang L; Ogawa T; Murai A; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Nishidate T; Okita K; Kutomi G; Sato N; Takemasa I; Torigoe T
    Biochem Biophys Res Commun; 2017 Apr; 485(3):651-657. PubMed ID: 28219643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance.
    Afonso J; Santos LL; Miranda-Gonçalves V; Morais A; Amaro T; Longatto-Filho A; Baltazar F
    Mol Carcinog; 2015 Nov; 54(11):1451-66. PubMed ID: 25263481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.